Suchergebnisse - "O'Donnell, Peter H"

PubPharm (156)

1

Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Milowsky, M. | O'Donnell, P. | Hoimes, C. | +20

2

Bladder-Preserving Trimodality Therapy With Capecitabine

enthalten in: Clinical genitourinary cancer | 2024

von Lynch, C. | Sweis, R. | Modi, P. | +6

3

A phase I trial of enzalutamide plus selective glucocorticoid receptor modulator relacorilant in patients with metastatic castration resistant prostate cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Desai, K. | Serritella, A. | Stadler, W. | +3

4

Health-related Quality of Life in Patients with Previously Treated Advanced Urothelial Carcinoma from EV-301 : A Phase 3 Trial of Enfortumab Vedotin Versus Chemotherapy

enthalten in: European urology | 2024

von Rosenberg, J. | Mamtani, R. | Sonpavde, G. | +28

5

Implementation of pharmacogenomics testing for precision medicine

enthalten in: Critical reviews in clinical laboratory sciences | 2024

von Kanegusuku, A. | Chan, C. | O'Donnell, P. | +1

6

Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130) : final overall survival analysis results from a randomised, controlled, phase 3 study

enthalten in: The Lancet. Oncology | 2024

von Grande, E. | Arranz, J. | De Santis, M. | +20

7

Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von O'Donnell, P. | Milowsky, M. | Petrylak, D. | +22

CommentIn: J Clin Oncol. 2023 Sep 1;41(25):4084-4086. - PMID 37490639

8

Phase II Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations

enthalten in: JCO precision oncology | 2023

von Doroshow, D. | O'Donnell, P. | Hoffman-Censits, J. | +8

CommentIn: JCO Precis Oncol. 2023 Aug;7:e2300293. - PMID 37535882

9

DPYD Testing : Time to Put Patient Safety First

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Baker, S. | Bates, S. | Brooks, G. | +19

CommentIn: J Clin Oncol. 2023 Aug 1;41(22):3875. - PMID 37267582

10

Implementation of pharmacogenomics into inpatient general medicine

enthalten in: Pharmacogenetics and genomics | 2023

von Chen, T. | O'Donnell, P. | Middlestadt, M. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]